Anti-CD30 immunotoxins with native and recombinant dianthin 30
- PMID: 7882380
- PMCID: PMC11037669
- DOI: 10.1007/BF01520292
Anti-CD30 immunotoxins with native and recombinant dianthin 30
Abstract
Immunotoxins were prepared with a Ber-H2 (anti-CD30) monoclonal antibody and native or recombinant dianthin 30, a ribosome-inactivating protein from Dianthus caryophyllus (carnation). Both immunotoxins selectively inhibited protein synthesis by CD30+ cell lines D430B (lymphoblastoid, infected with Epstein-Barr virus), L428 and L540 (both from Hodgkin's lymphoma). IC50 values (concentrations, as dianthin, causing 50% inhibition) ranged from 324 pM to 479 pM (immunotoxin with native dianthin 30) or from 45 pM to 182 pM (immunotoxin with recombinant dianthin 30). The effect of either immunotoxin on protein synthesis by the CD30+ cell line K562 (from a chronic myeloid leukaemia) was not different from that of free dianthin (IC50 higher than nM).
References
-
- Barbieri L, Battelli MG, Stirpe F. Ribosome-inactivating proteins from plants. Biochim Biophys Acta. 1993;1154:327. - PubMed
-
- Endo Y. Mechanism of action of ricin and related toxins on the inactivation of ribosomes. In: Frankel AE, editor. Immunotoxins. Boston: Kluwer; 1988. p. 75. - PubMed
-
- Ramakrishnan S, Fryxell D, Mohanraj D, Olson M, Li BY. Cytotoxic conjugates containing translational inhibitory proteins. Annu Rev Pharmacol Toxicol. 1992;32:579. - PubMed
-
- Vitetta ES, Thorpe PE, Uhr JW. Immunotoxins: magic bullets or misguided missiles? Immunol Today. 1993;14:252. - PubMed
-
- Pastan I, Chaudhary V, FitzGerald D. Recombinant toxins as novel therapeutic agents. Annu Rev Biochem. 1992;61:331. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources